iCardio.ai received FDA 510(k) clearance for its artificial intelligence software for interpretation of echocardiography. Offering a comprehensive imaging workflow and autonomous preliminary reporting, our artificial intelligence is now available in the largest market in the world.
“Our vision of the future of echocardiography – interpreted by machine:, more accurate, more expedited, and more cost-effective – is coming to fruition. Gone will be the days when cardiologists read echos in the dark, like someone driving without Google Maps. We envision a future where clinicians can spend more time with their patients,” according to a post on the company website.
“Our AI is already available in several imaging systems, thanks to our early believers – UltraLinQ Healthcare Solutions, deepc, HeartLab, and SARC MedIQ, and many others – representing exposure to millions of echocardiograms per year. The world of medicine is changing,” it adds.
